Methylphenidate for children and adolescents with autism spectrum disorder-Reference-Cited by-同舟云学术

Methylphenidate for children and adolescents with autism spectrum disorder

Published:2017-11-21 Issue:11 Volume:2017 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Sturman Nancy¹,Deckx Laura¹,van Driel Mieke L¹

Affiliation:

1. The University of Queensland; Primary Care Clinical Unit, Faculty of Medicine; Herston Brisbane Queensland Australia 4029

Publisher

Wiley

Subject

Pharmacology (medical)

Reference120 articles.

1. Handen BL Cochrane Review: Methylphenidate for core and ADHD-like symptoms in children aged 6 to 18 years with autism spectrum disorders (ASDs) [personal communication] Email to: N Sturman

2. Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder;Handen;Journal of Autism and Developmental Disorders,2000

3. Pearson DA Cochrane Review: Methylphenidate for core and ADHD-like symptoms in children aged 6 to 18 years with autism spectrum disorders (ASDs) [personal communication] Email to: N Sturman

4. Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms;Pearson;Journal of Child and Adolescent Psychopharmacology,2013

5. Use of methylphenidate in the treatment of children with autistic disorder;Quintana;Journal of Autism and Developmental Disorders,1995

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the Behavioral Effect of Psychostimulants in Children with Autism Spectrum Disorder: A Cross-Sectional Study;Neuropediatrics;2024-08-06

2. Evaluation of the Quality of Management Guidelines for Children and Adolescents With Autism Spectrum Disorder;Psychological Reports;2024-08-05

3. Attenuated responses to attention‐modulating drugs in the neuroligin‐3^R451C mouse model of autism;Journal of Neurochemistry;2024-08-02

4. 2023 clinical practice guidelines on autism spectrum disorder in children and adolescents in Singapore;Annals of the Academy of Medicine, Singapore;2024-04-29

5. An Update on Psychopharmacological Treatment of Autism Spectrum Disorder;Focus;2024-04